Medical rehabilitation company Saebo and Swiss medtech company Hocoma said today they will partner to offer a system combining both of their technologies for treatment of patients with moderate to mild impairments of the upper extremities.
The partnership will combine Saebo’s SaeboMas Mini rehabilitaiton tech and Hocoma’s ArmeoSenso robotic mobilization device, the companies said.
“Saebo is committed to helping patients around the globe achieve a new level of independence. Together with an industry leader such as Hocoma, we believe we can maximize the potential of our affordable and evidence-based solutions,” Saebo co-founder Henry Hoffman said in a prepared statement.
The companies said that they plant to deepen their partnership overtime, and that the combined technologies will be usabel at Rehabweek in London this week.
“We are very excited to be working with Saebo. Neurological disorders afflict thousands of people each year and by teaming up with another leading player in the industry, we expect to be able to help even more patients recover faster and with better long-term outcomes than conventional rehabilitation therapy can offer. Our ultimate goal is to provide all patients with a compact, affordable rehabilitation solution – regardless of the specific body parts affected by neurological damage,” Hocoma CEO and co-founder Dr. Gery Colombo said in a prepared statement.
Last week, Saebo said it won FDA clearance for its SaeboVR virtual activities of daily living rehabilitation system designed to engage neurological clients in physical and cognitive functional tasks.